Sepsis and septic shock are responsible for more than 200 000 deaths annually in the United States. 1 Recognition of lipopolysaccharide (LPS, a major structural component of the bacterial outer cell membrane) by host cells plays a major role in the pathogenesis of sepsis due to Gram-negative organisms. Normally, LPS elicits a protective inflammatory response aimed at elimination of the invading pathogen. This response is mediated to a large extent by CD14, a differentiation antigen expressed as a glycosylphosphatidylinositol-anchored membrane glycoprotein (mCD14) in myeloid lineage cells or as a soluble form (sCD14) in the serum. [2] [3] [4] In certain instances, uncontrolled progression of this beneficial inflammatory response results in serious tissue damage to the host and septic shock.
Variation in the inflammatory responses of inbred mouse strains to experimental challenge with purified LPS was established over 50 years ago. 5 Classically, two mouse strains, C3H/HeJ and the C57BL/10ScCr (together with its progenitor strain C57BL/10ScNCr), exhibit natural tolerance to otherwise lethal doses of LPS. 6, 7 Genetic analyses established that LPS hyporesponsiveness is under the control of a single locus on chromosome 4 named Lps. 8, 9 Toll-like receptor 4 (Tlr4) was identified as a critical component of LPS response on the basis of its location, expression pattern, biological function and presence of mutated Tlr4 alleles in both C3H/HeJ (Pro 712 His) and C57BL10/ScNCr (complete deletion of the gene) mouse strains. [10] [11] [12] Tlr4 is part of an ancient gene family that regulates antimicrobial host defense in plants, invertebrates and mammals. 13 Members of the Toll-like receptor (TLR) family share similar predicted protein structure consisting of an extracellular domain containing several leucine-rich repeats, a single transmembrane domain and an intracellular domain with homology to the IL-1R family and proven to be essential for cell signalling.
14 Tlr4 interacts with LPS-CD14 complexes to transduce the LPS signal across the membrane, inducing NF-B activation and expression of several proinflammatory cytokines including TNF␣. 15 Research into the role of TLRs in host defense is progressing rapidly and has clearly shown that innate host inflammatory responses to several structurally diverse microbial constituents are triggered through different TLRs. [16] [17] [18] [19] [20] [21] [22] We recently identified the mouse, C57BL/6J.KB2-mnd (B6.KB2-mnd) bearing the motor neuron degeneration (mnd) mutation, as being hyporesponsive to LPS. Measurement of LPS-induced spleen cell mitogenesis demonstrated that these mice have a phenotype strongly resembling that of C3H/HeJ (Figure 1a ). Splenocytes derived from F1 progeny of an outcross between B6.KB2-mnd and C3H/HeJ did not respond to LPS, suggesting the presence of a non functional Tlr4 allele in B6.KB2-mnd (Figure 1a) . In the present study, we compared the genotypes of 10 DNA markers (D4Mit323, D4Nds9, D4Mit25, D4Mcg6, D4Mcg24, D4Mcg25, D4Mcg82, D4Mcg5, D4Mit178 and D4Rck137) located on a 1.6 Mb chromosomal fragment overlapping Tlr4 in 53 classical and wild-derived mouse strains. 11, 23 This analysis shows that B6.KB2-mnd mice have an haplotype identical to and present only in C57BL/6J mice (data not shown). Thus, the B6.KB2-mnd haplotype for this region of chromosome 4 is different from that of the two LPS-hyporesponsive mouse strains C3H/HeJ and C57BL/10ScNCr suggesting the presence of a novel Tlr4 3 H]thymidine incorporation into splenocytes derived from C57BL/6J, C3H/HeJ, B6.KB2-mnd and F1 hybrids. Spleens were removed aseptically, gently homogenized and splenocytes were resuspended in 5 ml of cold complete RPMI 1640 (Gibco). Cells were loaded on a density separation medium (Lympholyte-M, Cedar Lane Laboratories), allowing the obtention of 12 × 10 6 to 40 × 10 6 viable cells per mouse spleen. Singlecell splenocytes suspensions were prepared at a final concentration of 2 × 10 6 cells/ml in RPMI 1640 medium containing 20% heat-inactivated fetal bovine serum (Clontech). Cells were cultured (100 l/well) in 96-well plates, stimulated with 1 g/ml of LPS (E. coli K235; Sigma) or 1.5 g/ml of Concanavalin A (Sigma) in RPMI 1640 medium and further incubated for 48 h at 37°C. During the last 6 h of incubation, 1 Ci Genes and Immunity mutated allele. We searched for Tlr4 gene alteration by RT-PCR amplification and Southern blot analysis. Total liver RNA from C57BL/6J and C57BL/6.KB2-mnd mouse strains was extracted and random primed first-strand Tlr4 cDNAs were amplified with primers 5Ј-TCATggCCTCCACTggTTgCAgAA-3Ј (position −33) and 3Ј-AgTTAgAgAgAAATCTggACA-5Ј (position 628) as described by us previously. 11 Amplified products were electrophoresed on agarose gel and directly sequenced. We identified the presence of a 167 bp deletion within B6.KB2-mnd Tlr4 cDNA (Figure 1b) . Mouse Tlr4 has three exons spread over 15 kb and several transcription start sites with major clusters located at different position depending of the origin of the RNA (Figure 2b ) (unpublished data). 24 The mutation identified in B6.KB2-mnd Tlr4 consists of a complete deletion of exon II and leads to a frameshift resulting in the appearance of a stop codon just downstream of the exon junction (Figure 2a  lower part) . The putative Tlr4 mutant protein is equivalent to the first 31 N-terminal residues of its wild-type counterpart (835 residues), predicting a truncated protein missing most of the extracellular domain, and the entire transmembrane and cytoplasmic domains. Thus, the mutation identified in the B6.KB2-mnd mice almost certainly results in a complete loss of function.
Southern blot analysis using exon II and intron II specific probes was performed on B6.KB2-mnd and C57BL/6J DNA samples. Altered band sizes were observed for all the restriction enzymes tested (BamHI, EcoRI, BglII, HindIII, and PstI) in B6.KB2-mnd mice suggesting a chromosomal rearrangement (data not shown). Figure 2c shows a graphic representation of the restriction maps of the C57BL/6J and B6.KB2-mnd Tlr4 genomic region surrounding exons II and III. From this analysis, it appears that an insertion of at least 8 kb is present in B6.KB2-mnd DNA. The chromosomal insertion site was mapped using PCR primers located within Tlr4 intron I, exon II and intron II to a region of exon II located between nucleotides 205 and 215 of the coding cDNA.
Mutant mnd mice have been proposed as a model of neuronal ceroid lipofuscinosis on the basis of abnormal accumulation of autofluorescent lipopigment in lysosomes of various cells. This mutant is on a B6.KB2 background (derived from a cross between B6.H-2 k and C57BL/6J) and exhibits a spontaneous adult-onset neurological disease with retinal degeneration and motor abnormality by 6 months of age, progressing to severe spastic paralysis and premature death. 25 The locus responsible for this defect is located on chromosome 8 and is most likely identical to a novel gene designated Cln8 (neuronal ceroid lipofuscinosis 8) which is mutated in patients showing progressive epilepsy (EPMR) with mental retardation. 26, 27 Outcrossing of the mnd mutation onto an AKR/J background (Tlr4 Pro712 ) results in an acceleration of the disease whereas outcrossing to C3H/HeJ (Tlr4 His712 ) does not affect the timing of the neurological disease. 28 The possibility that a mutation within Tlr4 influences the timing of neuronal ceroid lipofuscinosis is unknown. Nevertheless, several lines of evidence suggest that TNF␣ may play a role in the disease by modulating inflammation, 29 possibly implicating proximal cell signaling through CD14 and Tlr4. The presence of a mutated Tlr4 allele in mnd mutant mice provides an opportunity for further study of the role of this gene as a possible modulator for neuronal ceroid lipofuscinosis or other important neurological diseases both in mice and humans.
